• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)

IPO

Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing

Sai Parenteral's Ltd

Sai Parenteral's Ltd

    Registered Office : No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli,Ranga Reddy Telangana 500032 Phone : +91 79979 91301
    Fax :

    Email : cs@saiparenterals.com

    Website : https://www.saiparenterals.com

Initial public offer of 10,428,288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating to Rs. 408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of Rs. 5 each aggregating to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of 3,157,880 equity shares of face value of Rs. 5 each aggregating to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company. Price Band: Rs. 392 per equity share of face value of Rs. 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter.

Issue

Opens On

Closes On

24-Mar-2026

27-Mar-2026

Money Payable On

Application

Allotment

392.00

0.00

Minimum Application for shares in Nos : 38.0 Further Multiples of : 38.0

₹Cr

Lead Managers to the Issue

Project Cost (₹.Cr)

Project Financed through Current Offer (₹.Cr)

Post Issue Equity Share Capital (₹.Cr)

Issue Price (₹.Cr)

256.50

408.79

22.09

392.00

Arihant Capital Markets Limited

Projects
  • Capacity expansion and upgradation of manufacturing facilities
  • Establishment of a new R&D Centre
  • Repayment / prepayment of certain outstanding borrowings
  • Working capital requirements
  • Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
  • General corporate purposes
Promoted By
  • Anil Kumar Karusala
  • Vijitha Gorrepati
  • Karusala Aruna
Listing At
  • BSE
  • NSE
Registrar to the Issue
  • Bigshare Services Pvt Ltd